Literature DB >> 28761629

Atherogenic indices in stroke patients: A retrospective study.

Rajaragupathy Sujatha1, Subramanian Kavitha1.   

Abstract

Background: Stroke makes a significant cause of morbidity and mortality worldwide. Although derangements in the lipid profile have been suggested as a risk factor for the development of stroke, various studies show inconsistent results on the association between lipid profile and stroke. A very few studies have commented on the status of lipid indices in stroke patients.
Methods: After obtaining ethical medical records of the study populations were analyzed, and data collected from patients admitted to the hospital with clinically diagnosed stroke and control group consisted of apparently healthy volunteers selected from the master health checkup department. Baseline characteristics and lipid profile parameters and the number of days of hospital stay for stroke patients were collected. Lipid indices were calculated using following formulae. Atherogenic index of plasma (AIP) = log triglyceride/high-density lipoprotein cholesterol (HDLc), Castelli's Risk Index (CRI-I) = Total cholesterol/HDLc, CRI-II = Low density lipoprotein cholesterol/HDLc, atherogenic coefficient (AC) = (Total cholesterol-HDLc)/HDLc, and non-HDLc (NHC) = Total cholesterol-HDL.
Results: The study included 620 participants of which 290 were stroke patients and 330 healthy volunteers. 61% of stroke patients were hypertensives and 38% were diabetics 28% were both diabetic and hypertensives. In this study, the lipid parameters and the indices were significantly higher in stroke patients than the control group. Three indices, namely, CRI-I, AC, and NHC were found to be contributing to the risk of stroke significantly. There was no statistically significant correlation between the duration of hospital stay and lipid indices or individual parameters of lipid profile.
Conclusion: In this study, the atherogenic lipid indices were significantly higher in stroke patients compared to controls.

Entities:  

Keywords:  Atherogenic Indices; Lipid Profile; Stroke

Year:  2017        PMID: 28761629      PMCID: PMC5526781     

Source DB:  PubMed          Journal:  Iran J Neurol        ISSN: 2008-384X


Introduction

Stroke is defined as “an acute neurologic dysfunction of vascular origin with sudden (within seconds) or at least rapid (within hours) occurrence of symptoms and signs corresponding to the involvement of focal areas in the brain.”[1] It is one of the leading causes of mortality and disability globally. The prevalence of stroke in India varies in different regions of country, and the estimated prevalence rates increase from 0.3/1000 in < 45 years age group to 12-20/1000 in the 75-84 years age group.[2] There are several studies in India determining risk factors of stroke. Goldstein, et al.[3] described the various non-modifiable and modifiable risk factors of stroke. The non-modifiable risk factors include age, gender, ethnicity, and previous family history of stroke. The modifiable risk factors include hypertension, smoking, diabetes, asymptomatic carotid stenosis, atrial fibrillation, pre-existing cardiac disease, and hyperlipidemia. Abnormalities of serum lipids have traditionally been regarded as a risk factor for coronary artery disease but not for stroke. However, the relationship between lipids and stroke was elucidated and it has been made clear that the risk of stroke and amount of carotid atheroma can be reduced with cholesterol-lowering medications.[3] Thus, lipid profile abnormalities are found to have profound influences in the development and outcome of stroke. It has been emphasized that in an attempt to optimize the predictive capacity of the lipid profile, several lipoprotein ratios or “atherogenic indices” have been defined. The various atherogenic indices are atherogenic index of plasma (AIP), Castelli Risk Index I and II (CRI), atherogenic coefficient (AC), and non-high density lipoprotein cholesterol (HDLc) (NHC). AIP is based on two important parameters, serum triglyceride, and serum HDLc. The concurrent use of triglycerides and HDLc in this ratio reflects the multiple interactions among the metabolism of different lipoproteins and can be useful for predicting plasma atherogenicity. Based on the study by Dobiasova,[4] we suggest that AIP values of -0.3 to 0.1 are associated with low, 0.10-0.24 with medium and above 0.24 with high cardiovascular risk. It is calculated according to the following formula: AIP = Log (serum triglyceride/serum HDLc).[4] CRI-I and II are two important indicators of vascular risk, the predictive value of which is greater than the isolated lipid parameters. They are calculated as per the given formulae: CRI-I = Serum total cholesterol/Serum HDLc, CR-I II = Serum low-density lipoprotein (LDL)-cholesterol/Serum HDLc,[5] AC is calculated as: (Serum total cholesterol−Serum HDLc)/HDLc.[6] NHC represents the cholesterol content present in all the atherogenic lipoproteins. It is calculated as the difference between total cholesterol and high-density cholesterol (serum total cholesterol–serum HDLc). Studies have shown that lipid indices calculated from parameters of lipid profile were found to have better predictive capacity in cardiovascular disease.[7] However, there were no conclusive studies to show the association of atherogenic indices in stroke patients. This study was conducted to assess the various lipid indices in stroke patients and also compare the same with healthy controls. Stroke is associated with serious morbidity and disability which contributes to the burden caused by stroke. Longer the duration of hospital stay in stroke patients, more is the severity of stroke and vice versa. This study also aimed to correlate these lipid indices with the duration of hospital stay in stroke patients which can be considered as an index of the severity of stroke.

Materials and Methods

Ethical clearance was obtained from the Institutional Human Ethics Committee. The study group consists of patients admitted to the hospital with clinically diagnosed stroke during the period January 2015-2016. The control group consisted of apparently healthy volunteers selected from the master health checkup department. The medical records of the study participants were analyzed, and data collected include age, gender, lipid profile parameters (total cholesterol, HDL, LDL and triglyceride levels), and the number of days of hospital stay for stroke patients. All parameters were estimated using dedicated kits and reagents in autoanalyzer. Lipid indices were calculated using following formulae: AIP = Log (serum triglyceride/serum HDLc), CRI-I = Serum total cholesterol/serum HDLc, CRI-II = Serum LDL cholesterol/serum HDLc, AC = (Serum total cholesterol−serum HDLc)/serum HDLc, NHC = Serum total cholesterol-serum HDLc. All statistical analysis was performed with SPSS version 19. Data were expressed as mean ± standard deviation (SD). For comparison of variables, statistical test was done using Mann-Whitney U-test for skewed distribution and chi-square test for categorical variables. Odds ratio and 95% confidence interval was calculated. Factors found to be significant in the univariate analysis were subjected to logistic regression analysis. P < 0.050 was considered as statistically significant. Characteristics of the study population

Results

A total of 620 participants were included in the study, out of which 290 were cases and 330 were controls. Age and gender matched controls were included in the study. The most commonly associated comorbid conditions related to stroke was found to be hypertension and diabetes mellitus. The characteristics of the study population are described in table 1.
Table 1

Characteristics of the study population

Characteristics Cases Controls P
Number of participants290330
Age (year) (mean ± SD)60.48 ± 13.6158.78 ± 10.240.080
Gender [n (%)]
      Males200 (69.0)214 (64.8)0.305
      Females90 (31.0)116 (35.2)
Hypertension [n (%)]178 (61.4)--
Diabetes mellitus [n (%)]111 (38.3)-
The results of lipid profile and lipid ratios in the study population are given in table 2.
Table 2

Lipid profile parameters and lipid indices in study participants

Parameter Cases (mean ± SD) Controls (mean ± SD) P
Serum cholesterol (mg/dl)170.80 ± 44.00144.10 ± 28.92< 0.001*
Serum triglycerides (mg/dl)140.50 ± 82.0095.98 ± 37.25< 0.001*
Serum HDL (mg/dl)36.11 ± 10.4047.37 ± 10.87< 0.001*
Serum LDL (mg/dl)116.23 ± 38.6890.63 ± 29.06< 0.001*
AIP0.56 ± 0.270.26 ± 0.22< 0.001*
CRI-I4.99 ± 1.523.21 ± 1.16< 0.001*
CRI-II3.39 ± 1.262.06 ± 1.06< 0.001*
AC 3.99 ± 1.502.21 ± 1.16< 0.001*
NHC134.78 ± 41.2596.74 ± 30.32< 0.001*

AIP: Atherogenic index of plasma; CRI: Castelli Risk Index; AC: Atherogenic coefficient; NHC: Non-high density lipoprotein cholesterol; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; SD: Standard deviation

P < 0.050 was considered as statistically significant.

Among the 290 stroke patients, 251 (86.5%) had associated comorbid conditions such as hypertension, diabetes mellitus, coronary artery disease, atrial fibrillation, thyroid dysfunction, hyperhomocysteinemia and anemia. Cutoff levels of the atherogenic indices to assess cardiovascular risk were taken from previous studies.[4],[8] AIP value of < 0.1 was considered as low risk and ≥ 0.1 was considered high risk.[4] CRI-I values of < 4 and CRI-II values of < 3 were taken as low risk.[8] AC value of < 2 and NHC value of < 130 were considered to be low risk. Using these cutoff values, study participants were categorized as low- and high-risk individuals. 96.6% of stroke cases had AIP levels > 0.1 and only 81.5% of controls had AIP above the cutoff levels. 70.0% of cases had CRI-I levels > 4 and only 15.5% of controls had higher CRI-I levels. 59.7% of cases had CRI-II levels > 3 and only 13.6% of controls had higher CRI-II levels. 92.4% of cases had AC levels > 2 and only 44.2% of controls had AC above the cutoff levels. 53.4% of cases had NHC levels > 130 mg/dl and 11.8% controls had higher NHC levels. Chi-square test was performed to assess the significance between the two groups and the results are tabulated. Odds ratio was also calculated and the results are included in table 3.
Table 3

Association of atherogenic indices and stroke

Parameter Cases (%) Controls (%) P OR CI
AIP96.681.5< 0.001*6.343.18-12.65
CRI-I70.015.5< 0.001*12.768.64-18.85
CRI-II59.713.6< 0.001*9.366.32-13.86
AC 92.444.2< 0.001*15.359.44-24.95
NHC53.411.8< 0.001*8.565.70-12.85

AIP: Atherogenic index of plasma; CRI: Castelli Risk Index; AC: Atherogenic coefficient; NHC: Non-high density lipoprotein cholesterol; OR: Odds ratio; CI: Confidence interval

P < 0.050 was considered as statistically significant.

Further logistic regression analysis (Table 4) was performed and three indices, namely, CRI-I, AC, and NHC were found to be contributing to the risk of stroke significantly.
Table 4

Adjusted odds ratio using logistic regression

Parameter Adjusted odds ratio CI
CRI-I6.47012.52-16.58
AC5.1912.87-9.37
NHC 1.9121.11-3.28

CRI: Castelli Risk Index; AC: Atherogenic coefficient; NHC: Non-high density lipoprotein cholesterol; CI: Confidence interval

There was no significant correlation between the duration of hospital stay and any of the lipid profile parameters or lipid indices among the stroke patients.

Discussion

Stroke makes a significant cause of morbidity and mortality worldwide. There are several etiologies and risk factors which are associated with the development of stroke. Although derangements in the lipid profile have been suggested as a risk factor for the development of stroke, various studies show inconsistent results on the association between lipid profile and stroke.[9] Lipid profile parameters and lipid indices in study participants AIP: Atherogenic index of plasma; CRI: Castelli Risk Index; AC: Atherogenic coefficient; NHC: Non-high density lipoprotein cholesterol; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; SD: Standard deviation P < 0.050 was considered as statistically significant. Association of atherogenic indices and stroke AIP: Atherogenic index of plasma; CRI: Castelli Risk Index; AC: Atherogenic coefficient; NHC: Non-high density lipoprotein cholesterol; OR: Odds ratio; CI: Confidence interval P < 0.050 was considered as statistically significant. Adjusted odds ratio using logistic regression CRI: Castelli Risk Index; AC: Atherogenic coefficient; NHC: Non-high density lipoprotein cholesterol; CI: Confidence interval Calculations of various lipid ratios and indices may show the existence of association if any. These indices include AIP, CRI, AC, and NHC. In this study, stroke was found to be more prevalent among men (69%) compared to women, which is consistent with many previous studies in which males have 25-30% higher risk of developing stroke.[10] 61% of stroke patients had hypertension and 38% were diabetics 28% were both diabetic and hypertensives. Based on ATP III guidelines, 91% of stroke patients (n = 265) had alterations in one or more lipid parameters. All the parameters of lipid profile were significantly higher in cases when compared to controls. Our findings were inconsistent with studies by Shahar, et al.[11] and Bowman, et al.[12] which reported the lack of association between lipids and stroke. Lipid indices have been associated with increased cardiovascular risk in many previous studies.[4]-[6] A very few studies have commented on the status of lipid indices in stroke patients.[13],[14] In the present study, the lipid indices were significantly higher in stroke patients than the control group. With inconsistent lipid profile parameters between stroke patients and control subjects, the lipid indices show a significant increase in stroke patients compared to controls. Even if lipid profile fails to show any risk, calculation of lipid indices will help to show the true risk existing between lipid abnormality and stroke development. Study participants were categorized using cutoff levels for the various atherogenic indices. It was found that stroke cases had statistically significant individuals in the high-risk group as shown in table 3. Logistic regression analysis (Table 4) was performed and three indices, namely, CRI-I, AC, and NHC were found to be contributing to the risk of stroke significantly. CRI-I was also a significant risk factor for stroke development which is similar to the study by Zhang, et al.[15] which showed a positive association of CRI-I with the risks of total and ischemic stroke in both men and women. AC is a measure of cholesterol in LDL and very LDL fractions with respect to HDL. As AC value increases, the risk for developing cardiovascular diseases increase and vice versa. This study shows that higher levels of AC are a significant risk factor for stroke development. NHC was found to be a significant risk factor for the development of stroke (odds ratio-1.912). This finding was consistent with the study by Wu, et al.[16] which stated that higher serum NHC is associated with increased risk for stroke independent of other potential confounding factors. Further this study also assessed the severity of stroke patients by analyzing the duration of hospital stay. Pearson’s correlational analysis revealed that there was no statistically significant correlation between the duration of hospital stay and lipid indices or individual parameters of lipid profile. Patil and Raghuwanshi[17] concluded that since all lipid parameters showed a considerable decrease on 7th day, as the stroke severity decreased, it could be proportionally linked with the severity of stroke. However, there are no previous studies which show an association between the lipid indices and severity of stroke. Hence, this study shows that lipid indices may help in assessing the risk of stroke if not the severity of the same. This study may also help guide future trials attempting to relate lipid alterations with the occurrence of stroke events.

Conclusion

In the present study, the atherogenic lipid indices were significantly higher in stroke patients compared to controls. Three indices, namely, CRI-I, AC, and NHC were found to be contributing to the risk of stroke significantly. These can be easily estimated from routinely done parameters and is therefore a cheaper alternative to other costly diagnostic tests and modalities. The inclusion of these indices in routine clinical setup may help to identify at risk individuals and guide effective treatment modalities in stroke patients. The study did not include the other comorbid conditions that are associated with stroke. Prospective studies can be undertaken to assess the various complications associated with stroke and its association with the various lipid indices.
  15 in total

1.  Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.

Authors:  Milada Dobiásová
Journal:  Clin Chem       Date:  2004-07       Impact factor: 8.327

Review 2.  Stroke in young: an Indian perspective.

Authors:  Kameshwar Prasad; Kapil K Singhal
Journal:  Neurol India       Date:  2010 May-Jun       Impact factor: 2.117

3.  Comparison of four nontraditional lipid profiles in relation to ischemic stroke among hypertensive Chinese population.

Authors:  Xiaofan Guo; Zhao Li; Guozhe Sun; Liang Guo; Liqiang Zheng; Shasha Yu; Hongmei Yang; Guowei Pan; Yonghong Zhang; Yingxian Sun
Journal:  Int J Cardiol       Date:  2015-08-04       Impact factor: 4.164

4.  Nontraditional serum lipid variables and recurrent stroke risk.

Authors:  Jong-Ho Park; Juneyoung Lee; Bruce Ovbiagele
Journal:  Stroke       Date:  2014-09-18       Impact factor: 7.914

5.  Total and high-density lipoprotein cholesterol and stroke risk.

Authors:  Yurong Zhang; Jaakko Tuomilehto; Pekka Jousilahti; Yujie Wang; Riitta Antikainen; Gang Hu
Journal:  Stroke       Date:  2012-04-10       Impact factor: 7.914

6.  Non-high-density lipoprotein cholesterol vs low-density lipoprotein cholesterol as a risk factor for ischemic stroke: a result from the Kailuan study.

Authors:  Jianwei Wu; Shengyun Chen; Liping Liu; Xiang Gao; Yong Zhou; Chunxue Wang; Qian Zhang; Anxin Wang; Mohammed Hussain; Baoying Sun; Shouling Wu; Xingquan Zhao
Journal:  Neurol Res       Date:  2013-04-16       Impact factor: 2.448

7.  Cholesterol and coronary heart disease: predicting risks by levels and ratios.

Authors:  B Kinosian; H Glick; G Garland
Journal:  Ann Intern Med       Date:  1994-11-01       Impact factor: 25.391

8.  Cholesterol and the risk of ischemic stroke.

Authors:  Thomas S Bowman; Howard D Sesso; Jing Ma; Tobias Kurth; Carlos S Kase; Meir J Stampfer; J Michael Gaziano
Journal:  Stroke       Date:  2003-11-13       Impact factor: 7.914

9.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

10.  Lipid profile in cerebrovascular accidents.

Authors:  Mansoureh Togha; Mohamad Reza Gheini; Babak Ahmadi; Patricia Khashaiar; Soodeh Razeghi
Journal:  Iran J Neurol       Date:  2011
View more
  12 in total

1.  Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial.

Authors:  Abbas Ali Sangouni; Shima Abdollahi; Hassan Mozaffari-Khosravi
Journal:  BMC Cardiovasc Disord       Date:  2022-05-10       Impact factor: 2.174

2.  Differences in Lipid Profiles and Atherogenic Indices Between Hypertensive and Normotensive Populations: A Cross-Sectional Study of 11 Chinese Cities.

Authors:  Wenke Cheng; Lili Wang; Siwei Chen
Journal:  Front Cardiovasc Med       Date:  2022-05-17

3.  Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

Authors:  Gabriel Tayguara Silveira Guerreiro; Larisse Longo; Mariana Alves Fonseca; Valessa Emanoele Gabriel de Souza; Mário Reis Álvares-da-Silva
Journal:  Hepatol Int       Date:  2021-03-10       Impact factor: 6.047

4.  Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in Egyptians.

Authors:  Walaa A Keshk; Doaa H Zineldeen; Yasser A El-Heneedy; Azza A Ghali
Journal:  Neurol Sci       Date:  2018-04-10       Impact factor: 3.307

5.  The Clinical Importance of the Plasma Atherogenic Index, Other Lipid Indexes, and Urinary Sodium and Potassium Excretion in Patients with Stroke.

Authors:  Tuba Tulay Koca; Cemile Buket Tugan; Muhammet Seyithanoglu; Burhan Fatih Kocyigit
Journal:  Eurasian J Med       Date:  2019-06

6.  Comment on "The Clinical Importance of the Plasma Atherogenic Index, Other Lipid Indexes, and Urinary Sodium and Potassium Excretion in Patients with Stroke".

Authors:  Erkan Cure; Medine Cumhur Cure
Journal:  Eurasian J Med       Date:  2020-06-05

7.  Atherogenic index of plasma as a marker of cardiovascular risk factors in Mexicans aged 18 to 22 years.

Authors:  Ashuin Kammar-García; Patricia López-Moreno; María Elena Hernández-Hernández; Angélica María Ortíz-Bueno; María de Lurdez Consuelo Martínez-Montaño
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-21

8.  Impact of oscillatory-cycloid vibration interventions on body composition, waist and hip circumference, and blood lipid profile in women aged over 65 years with hypercholesterolaemia.

Authors:  Anna M Piotrowska; Monika Bigosińska; Halina Potok; Urszula Cisoń-Apanasewicz; Olga Czerwińska-Ledwig; Łukasz M Tota; Roxana Zuziak; Tomasz Pałka; Wanda Pilch
Journal:  Prz Menopauzalny       Date:  2018-12-31

9.  Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis.

Authors:  Larisse Longo; Pabulo Henrique Rampelotto; Eduardo Filippi-Chiela; Valessa Emanoele Gabriel de Souza; Fernando Salvati; Carlos Thadeu Cerski; Themis Reverbel da Silveira; Cláudia P Oliveira; Carolina Uribe-Cruz; Mário Reis Álvares-da-Silva
Journal:  World J Hepatol       Date:  2021-12-27

10.  Effect of omega-3 supplementation on cardiometabolic indices in diabetic patients with non-alcoholic fatty liver disease: a randomized controlled trial.

Authors:  Abbas Ali Sangouni; Zahra Orang; Hassan Mozaffari-Khosravi
Journal:  BMC Nutr       Date:  2021-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.